Urdu Translation of Duke Activity Status
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04739163 |
|
Recruitment Status :
Completed
First Posted : February 4, 2021
Last Update Posted : May 20, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Heart Diseases |
Literature suggested that Duke Activity Index (DASI) is a questionnaire originally developed in English To evaluate the functionality. DASI was used primarily to assess patients with cardiovascular diseases such as coronary artery disease, heart failure, myocardial ischemia, and infarction. In clinical practice, DASI can be used to know the effects of medical treatments and cardiac rehabilitation and to assist clinical decisions In controlled clinical trials, DASI can also be used to assess interventions and as a component for assessing the costs/benefits of treatment.
Studies demonstrated that DASI is characterized as a questionnaire with good functional ability, evidence of validity, usefulness, and great clinical and scientific applicability, it seems to be a useful tool for evaluating cardiac patients. So, to be used with Brazilian CVD patients it is necessary to validate DASI and verify its psychometric properties in this population.
| Study Type : | Observational |
| Actual Enrollment : | 18 participants |
| Observational Model: | Other |
| Time Perspective: | Cross-Sectional |
| Official Title: | Translation and Cross-cultural Adaptation of the Duke Activity Status Index to Urdu |
| Actual Study Start Date : | October 1, 2020 |
| Actual Primary Completion Date : | March 1, 2021 |
| Actual Study Completion Date : | April 1, 2021 |
- Translation of Duke Activity Status Index (DASI) in Urdu [ Time Frame: 6 months ]The Duke Activity Status Index Scale (DASI) is a questionnaire, originally developed in English to assess the functional capacity. DASI has been used mainly to evaluate patients with cardiovascular diseases, such as coronary artery disease, heart failure, myocardial ischemia and infarction.
- validity & reliability of Duke Activity Status Index Scale (DASI) in Urdu version [ Time Frame: 6 months ]Reliability and validity are concepts used to evaluate the quality of research. They indicate how well a method, technique or test measures something. Reliability is about the consistency of a measure, and validity is about the accuracy of a measure.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 22 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Individuals have enough education level to understand Urdu and English as well with a body mass index between 18.6 and 39.9 kg/m with the diagnosis of cardiovascular diseases such as coronary artery disease, valvular heart disease, arrhythmia with at least one symptom11 such as chest pain, palpitations, fatigue, or dyspnea, and physician referral to exercise testing.
Exclusion Criteria:
- Individual is unable to read the questionnaire, who have cognitive deficits screened by Mini-Mental State Examination according to the cut-off points and Hospitalization two months before as well as acute illness, fever, or severe physical limitation that would prevent from doing the exercise test.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04739163
| Pakistan | |
| AllamaIqbal hospital | |
| Sialkot, Punjab, Pakistan, 51040 | |
| Principal Investigator: | Mehwish Waseem, MSPT(CPPT) | Riphah International University |
| Responsible Party: | Riphah International University |
| ClinicalTrials.gov Identifier: | NCT04739163 |
| Other Study ID Numbers: |
REC/00783 Abdul Majid Saeed |
| First Posted: | February 4, 2021 Key Record Dates |
| Last Update Posted: | May 20, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Duke activity status index Heart Diseases Tool Translation |
|
Heart Diseases Cardiovascular Diseases |

